You are hurting them. If you do not panic and sell as well as many other longs they cannot make a financial killing. Plus sooner is better for them then latter. They don't want to wait around and see how this plays out. If they would wait Kerx just might do well and then they would be in a bit of a mess. They cannot control the future as many things may happen. They can control people through fear and manipulation.
It was posted on Schwab. It referred to a Nephrologist but no name given, Here is the article
Keryx Biopharma (NASDAQ: KERX) was pressured early on Monday following negative comments from analyst Bart Classen of Summer Street. Classen recently hosted a call with a nephrologist, and he believes ferric citrate will have a tough time competing. "We recently hosted a conference call to discuss Keryx s (KERX) ferric citrate for controlling serum phosphorous levels in patients on dialysis. The product is an oral small molecule. The FDA recently approved the product, and investors are interested in predicting how successful the product launch will be. We had a nephrologist discuss the market for phosphate binders. Of the US dialysis market, 30% is controlled by Fresenius (FMS) dialysis centers, and they prefer to use phosphate binders they developed and sell themselves," said Classen. "According to our MCRI nephrology consultant, approximately 50% of the patients receive Sanofi s (SNY) Renvela, and this product already has an authorized generic with additional generic competitors expected in the foreseeable future. Some patients take generic calcium acetate and calcium carbonate products. The MCRI consultant we spoke with believes Keryx s ferric citrate will have a tough time competing with generic Renvela, and he believes ferric citrate will be used as second-line therapy for those who cannot tolerate generic products," he added. I do not give much credence
to experts who remain nameless!
We need more articles like Brean posted. Good solid analysis demonstrating the benefits of z. This will be far more powerful than a correction by NYT.
Agree 100% Sadie. We need to stop spinning the negative as well. Let it die and the positives will bury it.
Conveniently omitted this part, eh!
Explanation of Responses:
1. Sale of a total of 144,237 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the
vesting of 250,000 shares of restricted stock on September 5, 2014, related to a corporate milestone. Mr. Oliviero had no discretion with respect
to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
2. Includes 44,161 shares of restricted stock. In addition, Mr. Oliviero holds 276,639 stock options.
You cannot get into a #$%$ contest with this type of investor. They will just throw more lies at you and find more ways to drum up neg press. Ignore them that is the best approach. Do not give them legs to keep running up against you